Genspera Inc (OTCQB:GNSZ)

0.95
Delayed Data
As of Mar 02
 -0.04 / -4.04%
Today’s Change
0.54
Today|||52-Week Range
1.42
+48.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$32.4M

Company Description

GenSpera, Inc. is a development-stage pharmaceutical company, which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of cancerous tumors, including prostate, brain and other cancers. Its technology platform combines, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that targets the release of the drug only within the tumor. The company was founded by Craig A. Dionne John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in San Antonio, TX.

Contact Information

GenSpera, Inc.
2511 North Loop 1604 West
San Antonio Texas 78258
P:(210) 479-8112
Investor Relations:

Employees

Shareholders

Individual stakeholders2.16%
Mutual fund holders--
Other institutional--

Top Executives

Craig A. DionneChairman, President, CEO, CFO & CAO
Russell B. RichersonChief Operating Officer & Secretary

To view my watchlist

Not a member yet?

Sign up now for a free account